Tag: biotech
-

Andarix Pharmaceuticals Advances Targeted Peptide Therapy Platform for Rare Cancers
CEO to Present at Major Industry Summit as Company Gains Momentum in Personalized Cancer Treatment BOSTON – July 23, 2025 – Andarix Pharmaceuticals, a clinical-stage biotechnology company pioneering targeted peptide therapies for rare cancers, today announced that CEO Chris Adams will present at the 3rd Targeted Radiopharmaceuticals Supply Chain & Manufacturing Summit in Boston on July 23-24, 2025.…